STOK (Stoke Therapeutics Inc) Earnings per share for the last four quarters

Stoke Therapeutics Inc (STOK) - corporate logo

Stoke Therapeutics develops RNA therapies for CNS pathologies, leveraging the success of the drug STK-001. The orphan status of these diseases ensures complete patient loyalty within this ecosystem. Annual EPS (TTM) growth statistics visualize the earnings per share trend, where the -634.00 metric determines the parameter status. Exclusive patents and stringent FDA oversight protect the business, creating high barriers to entry for new players.

Stoke - STOK Net earnings per share (EPS TTM) (period 02/11/2024 - 11/17/2026)

Stoke Corp - analytical breakdowns and key metrics (STOK)

- current price and projected stock value:
- business market valuation indicators:
Initial company analysis:Stoke Therapeutics, Inc.
Product sample of Stoke

The expertise of the Stoke Therapeutics (STOK) team in RNA therapy and the success of its R&D strategy establish a foundation for long-term profit scaling. By analyzing the relative EPS YoY TTM growth rate, an investor can observe the percentage change in net income per share over a rolling year, which allows for an assessment of the business's actual capitalization speed and the determination of the asset's fair market value.

Competitor analysis for Stoke Therapeutics

Earnings per share for the trailing year TEM (Tempus AI Inc)|QGEN (Qiagen Group) - Net earnings per share for the last 12 months|Earnings per one share for the last 12 months IONS (Ionis Pharma)|Earnings per share for the last twelve months Repligen|Earnings per share for the last twelve months RNA|Net earnings per share (EPS TTM) CRSP|Earnings per share for the last twelve months WGS (GeneDx)|Ultragenyx Pharmaceutical - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) Beam Tx BEAM|Sarepta Therapeutics - Net earnings per share (EPS TTM)|Twist Bioscience (TWST) - Net earnings per share for the last 12 months|TXG: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Intellia Therapeutics Inc (NTLA)|Net earnings per share for the last 12 months BLFS|Net earnings per one share for the last twelve months Wave Pharma WVE|Net earnings per share for the last 12 months MAZE (Maze Tx)|SION - Net earnings per one share for the last twelve months|Prime Medicine - Net earnings per share for the last 12 months|Taysha Gene Therapies Inc (TSHA) - Net earnings per one share for the last twelve months|uniqure.com - Net earnings per share (EPS TTM)|Net earnings per share for the trailing year MeiraGTx Corp (MGTX)|REGENXBIO (RGNX) - Earnings per share for the last twelve months|SLDB - Net earnings per share for the last four quarters|OCGN (ocugen.com) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Pacific Biosciences of California, Inc. PACB|Net earnings per share (EPS TTM) BNTC|Net earnings per share for the last four quarters Design Pharma|Net earnings per share (EPS TTM) RCKT (Rocket Corp)|FDMT - Net earnings per share for the last 12 months|Lexeo - Net earnings per share (EPS TTM)|KRRO - Net earnings per share (EPS TTM)|EDIT: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months SLN|Net earnings per share for the last 12 months PRQR|Net earnings per one share for the last twelve months Codexis CDXS|Earnings per share for the last twelve months Sangamo BioSciences (SGMO)|Net earnings per share (EPS TTM) Nautilus Biotechnology Inc (NAUT)|Net earnings per share (EPS TTM) MGX (Metagenomi Inc.)|Precision BioSciences - Earnings per share for the last twelve months|generationbio.com - Net earnings per share (EPS TTM)|BOLD: Earnings per share for the last twelve months|XCUR (Exicure Corp) - Net earnings per share for the last 12 months|Earnings per share for the last 12 months IMNN|Earnings per share for the last twelve months RXi Pharmaceuticals|Net earnings per share (EPS TTM) mustangbio.com|Net earnings per share (EPS TTM) RNAZ|Earnings per share for the last twelve months BNGO (Bionano Genomics)|Earnings per share for the last twelve months Applied DNA Sciences APDN|Net earnings per share for the last four quarters bluebird bio Inc. (BLUE)|IPA - Earnings per share for the last twelve months|Earnings per share for the trailing year OMGA (Omega Therapeutics)|OMIC: Net earnings per share (EPS TTM)|RGLS (Regulus Therapeutics Inc.) - Earnings per share for the last twelve months|Earnings per share for the last twelve months Syros Pharmaceuticals Inc.|Telesis Bio Inc. (TBIO) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months traconpharma.com (TCON)|Earnings per share for the last four quarters UBX